Skip to search formSkip to main contentSkip to account menu
Antimicrobial Resistance in Haemophilus influenzae
TLDR
Haemophilus influenzae is a major community-acquired pathogen causing significant morbidity and mortality worldwide, and strains with alterations in penicillin binding proteins, particularly PBP3 (β-lactamase negative ampicillin resistant and β-l lactamase positive amoxicillin-clavulanate resistant), are increasing in prevalence.
View on Publisher
The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
TLDR
These data demonstrate the continued evolution of and geographical variation in bacterial resistance and highlight the need for appropriate prescribing of antimicrobials in CARTI, using agents with adequate activity, based on local susceptibility profiles and PK/PD parameters.
View on PubMed
Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States.
TLDR
Differences in proportions of respective AMP-resistant genes in H. influenzae isolates between the two countries might reflect differences in antibiotic agents ordinarily given to outpatients with community-acquired bacterial infections.
View on PubMed
Antimicrobial resistance in Streptococcus pneumoniae: an overview.
  • P. Appelbaum
  • Medicine, Biology
    Clinical infectious diseases : an official…
  • 1 July 1992
TLDR
Pneumococcal resistance has been described in Zambia, Japan, Malaysia, Pakistan, Bangladesh, Chile, and Brazil; information from other African, Asian, and South American countries is not available.
View on PubMed
Diversity of Ribosomal Mutations Conferring Resistance to Macrolides, Clindamycin, Streptogramin, and Telithromycin in Streptococcus pneumoniae
TLDR
Twenty-two macrolide-resistant mutants selected in vitro from 5 parental strains of macrolid-susceptible Streptococcus pneumoniae by serial passage in various macrolides were studied, finding no mutations in L22, L4, or 23S rRNA could be detected.
View on Publisher
The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
  • P. Appelbaum
  • Medicine, Biology
    Clinical microbiology and infection : the…
  • 2006
TLDR
The treatment options available for these infections are now severely compromised and thus new classes of antimicrobial agents effective against MRSA, VISA and VRSA are urgently required.
View on PubMed
Comparison of Multiple-Locus Variable-Number Tandem-Repeat Analysis with Pulsed-Field Gel Electrophoresis, spa Typing, and Multilocus Sequence Typing for Clonal Characterization of Staphylococcus…
TLDR
The results suggest that MLVA may be reliable in shorter-term S. aureus epidemiological studies, including analyses of outbreaks and hospital-to-hospital strain transmission events and those performing routine microbiological analyses within medical centers.
View on Publisher
Mutations in 23S rRNA and Ribosomal Protein L4 Account for Resistance in Pneumococcal Strains Selected In Vitro by Macrolide Passage
TLDR
To the authors' knowledge, this is the first description of mutations in 23S rRNA genes or ribosomal proteins in macrolide-resistant S. pneumoniae strains.
View on ASMUSA
Antistaphylococcal Activity of Ceftobiprole, a New Broad-Spectrum Cephalosporin
TLDR
Ceftobiprole is a novel cephalosporin with expanded activity against gram-positive bacteria and single-passage selections showed very low frequencies of resistance to ceftoiprole irrespective of genotype or phenotype.
View on ASMUSA
Two New Mechanisms of Macrolide Resistance in Clinical Strains ofStreptococcus pneumoniae from Eastern Europe and North America
TLDR
Twenty strains with unusual ML or MSB phenotypes which did not harbor erm(B) ormef(A) phenotypes were studied and macrolide resistance mechanisms from clinical isolates are similar to those recently described for laboratory-derived mutants.
View on Publisher
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License